Innovating Works
Mostrando 1 al 20 de 26 resultados
EuroGCT: European consortium for communicating gene- and cell-based therapy information. THE UNIVERSITY OF EDINBURGH tramitó un H2020: The European Consortium for Communicating Gene and Cell Therapy Information (EuroGCT) unites 49 partner organisations and institutions across Europe, including the major European advanced therapies le...
2021-02-01 | Financiado
PID2021-123013OB-I00: BIOMATERIALES BIOINSPIRADOS PARA MODELAR LA INTERACCION CELULA-MATRIZ EXTRACELULAR EN LA LATENCIA DEL CANCER DE MAMA Y LA METASTASIS OSEA ASOCIACION INSTITUTO BIODONOSTIA tramitó un AEI: LOS MATERIALES SINTETICOS PERMITEN UN CONTROL INDEPENDIENTE DE LAS PROPIEDADES BIOFISICAS Y BIOQUIMICAS Y, EN LAS ULTIMAS DECADAS, HAN PERMITIDO REALIZAR ESTUDIOS INNOVADORES SOBRE COMO LAS CELULAS PE...
2021-01-01 | Financiado
CIRCULAR VISION: Circular DNA in diagnosis and disease models KOBENHAVNS UNIVERSITET tramitó un H2020: Many human diseases, including cancers and inflammatory disorders, are associated with the production of ‘circular DNA’ from chromosomes. These molecules have potential as biomarkers, and in the case...
2020-10-01 | Financiado
HEALIKICK: A modular strategy for the repair of critical sized bone fractures UNIVERSITY OF GLASGOW tramitó un H2020: Disruptive technologies for bone regeneration must be able to tackle complex fracture environments which have developed into non-union bone defects. These types of fracture are common and increasingly...
2020-06-01 | Financiado
PID2020-119715GB-I00: DESCUBRIMIENTO DE LAS PALABRAS EPIGENETICAS DE LA REGULACION CELULAR MEDIANTE EL DESARROLLO DE ALGORITMOS COMPUTACIONALES DE ANALISIS DE DATOS EPIGENOMICOS ASOCIACION INSTITUTO BIODONOSTIA tramitó un AEI: CELL REGULATION IS ORCHESTRATED BY THE CROSS-TALK OF DIFFERENT TYPES OF MOLECULES SUCH AS DNA, RNA, MICRORNAS, PROTEINS, ETC. THESE MOLECULES BUILD UP THE “HARDWARE” USED BY THE CELL TO IMPLEMENT THE...
2020-01-01 | Financiado
TBMED: A testing bed for the development of high-risk medical devices FUNDACION CIDETEC tramitó un H2020: TBMED will establish an open innovation testing bed specialized in the development of high-risk devices (≥Class IIb). Due to a long reimbursement processes, patient access to innovative high-risk medi...
2019-01-01 | Financiado
ESCALON: European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM tramitó un H2020: Hepatobiliary malignancies represent a major cause of mortality globally and are uniquely aggressive in Latin America. The most common tumors are: hepatocellular carcinoma (HCC) affecting young indivi...
2019-01-01 | Financiado
SAF2017-92696-EXP: GENERACION DE SISEMAS "LAB-ON-A-CHIP" PARA INVESTIGACION EN ENFERMEDADES NEUROMUSCULARES ASOCIACION INSTITUTO BIODONOSTIA tramitó un AEI: LA FUNCION CONTRACTIL DEL MUSCULO ESQUELETICO ESTA REGULADA POR SISTEMAS NEURONALES QUE INTERACTUAN CON LAS FIBRAS MUSCULARES A TRAVES DE LA UNION NEUROMUSCULAR (UNM), LA UNM ES UNA SINAPSIS QUIMICA Q...
2017-01-01 | Financiado
FLEXPOL: Antimicrobial FLEXible POLymers for its use in hospital environments FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. tramitó un H2020: FLEXPOL aims to develop a pilot line for the production of a cost effective antimicrobial (AM) adhesive film for its use in hospitals. The obtained adhesive film will inhibit growth of a wide range of...
2017-01-01 | Financiado
EUROlinkCAT: EUROlinkCAT: Establishing a linked European Cohort of Children with Congenital Anomalies ST GEORGES HOSPITAL MEDICAL SCHOOL tramitó un H2020: Over 130,000 children born in Europe every year will have a congenital anomaly (CA; birth defect). These CAs, which are often rare diseases, are a major cause of infant mortality, childhood morbidity...
2017-01-01 | Financiado
BFU2016-77987-P: OPTIMIZACION DE LA REPROGRAMACION CELULAR MEDIANTE LA RECONSTRUCCION TOTAL PAISAJE EPIGENETICO DE WADDINGTON USANDO TECNICAS "BIG DATA" -OMICAS ASOCIACION INSTITUTO BIODONOSTIA tramitó un AEI: EL PAISAJE EPIGENETICO DE WADDINGTON ES UNA “METAFORA” UTILIZADA PARA ILUSTRAR EL DESARROLLO EMBRIONARIO, EN PARTICULAR LA DIFERENCIACION CELULAR. WADDINGTON HIPOTETIZO ESTE CONCEPTO EN 1957 A PARTIR...
2016-01-01 | Financiado
IJCI-2015-26309: - ASOCIACION INSTITUTO BIODONOSTIA tramitó un AEI: 2015-01-01 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.